{"id":"W2078035712","doi":"10.2147/vhrm.s55246","title":"Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk","year":2014,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Janssen Research and Development; Bayer HealthCare","keywords":"Rivaroxaban; Medicine; Atrial fibrillation; Warfarin; Intensive care medicine; Stroke (engine); Dosing; Dabigatran; Anticoagulant; Apixaban; Edoxaban; Clinical trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001389731,0.0004085934,0.00173214,0.0003682606,0.0002950173,0.00006363472,0.00005184294,0.0001604088,0.000005190386],"category_scores_gemma":[0.0001825642,0.0002955638,0.0003745989,0.0002989085,0.00003935343,0.0001026154,0.0001233538,0.0002258391,0.000003250027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000193375,"about_ca_system_score_gemma":0.0001143928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001630819,"about_ca_topic_score_gemma":0.00003551131,"domain_scores_codex":[0.997326,0.0002478572,0.0009098708,0.0006627508,0.0004146135,0.0004389687],"domain_scores_gemma":[0.9980789,0.0002648053,0.0009147932,0.0004027427,0.00006054387,0.0002781893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001978442,0.000005664534,0.2129865,0.02379216,0.0008348509,0.000002242525,0.00002933297,0.00008145765,8.62339e-11,0.0008465462,0.00008727892,0.7611362],"study_design_scores_gemma":[0.005001239,0.0004012642,0.01831557,0.005513542,0.003658282,0.000002694644,0.00002464776,0.001169814,2.227692e-9,0.00005909897,0.9655415,0.0003123437],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001700142,0.9837139,0.007834282,0.00008992535,0.0002435794,0.00628898,0.00003180558,0.0000397982,0.00005761235],"genre_scores_gemma":[0.00003200206,0.97241,0.02622747,0.00004836252,0.0009364125,0.000009670748,0.0002021046,0.0000570538,0.00007694432],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9654542,"threshold_uncertainty_score":0.9999496,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05452617617708271,"score_gpt":0.3750624257402439,"score_spread":0.3205362495631612,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}